Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 419

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 419
---
 the amortization payment due under the Oramed Note on the March 21, 2025 and (y) $300,000 of such payment to purchase warrants (the “Purchased Warrants”) to purchase an aggregate of 114,285 (on a post-Reverse Stock Split basis) shares of Common Stock with an exercise price of $402.50 per share (on a post-Reverse Stock Split basis).

Pursuant to the Oramed Letter Agreement, the parties agreed that, notwithstanding the definition of the “Exercise Eligibility Date” in the CS-5 Warrant, Oramed may immediately exercise the CS-5 Warrant with respect to up to 1,062,500 (subject to adjustment as provided therein) shares of Common Stock subject to such warrant at any time after September 20, 2024. The parties further agreed, upon receipt of the Specified September Payment, (i) that notwithstanding the minimum Liquidity (as defined therein) requirements set forth in Section 7(b)(x) of the Oramed Note, the Company and its Subsidiaries (as defined therein) shall be required to maintain the following minimum liquidity during the specified time periods instead: from and after September 19, 2024 until the Maturity Date, $0, and (ii) to extend the due date of the $20,000,000 amortization payment from September 23, 2024 to September 30, 2024.

On October 2, 2024, the Company and Oramed entered into a Consent and Side Letter (the “Consent and Side Letter”), pursuant to which Oramed agreed to extend the due date of the September 23, 2024 payment to October 7, 2024. Oramed has agreed to further extend such due date to October 8, 2024 to allow additional time to close the Company’s convertible debt financing that was announced earlier the same day.

The above descriptions of the Oramed Letter Agreement and the Consent and Side Letter are not complete and are qualified in their entirety by reference to the full text of the Oramed Letter Agreement and the Consent and Side Letter, copies of which are filed as exhibits to the registration statement of which this prospectus forms a part.**

<div align='center'>272</div>

**Amended and Restated Security Agreement

On September 21, 2023, we and the Guarantors entered into a security agreement (the “Security